drug safety

Pharmacy Groups Warn Trump About Drug ImportsNACDS and APhA warn that letting Americans buy foreign drugs could be disastrous.
Will Gottlieb’s Faster Drug Approvals at FDA Help or Harm?
Will Gottlieb’s Faster Drug Approvals at FDA Help or Harm?Gottlieb and Trump want faster drug approvals to help more patients, but studies show faster approvals might cause harm.
More States Mandate Prescription Drug Monitoring ProgramsA look at PDMPs in PA—what they are doing and how they are helping patients.
Trimester zero (Part 1 of 2)Preconception care is primary prevention. The goal is to affirm pregnancy intention, reduce any potential harm, and recognize modifiable risk factors related to pregnancy while stratifying pregnancies on a continuum of low- to high-risk.
Oral syringes dose more accurately than cupsParents are less likely to make dosing errors when giving their child liquid medications if they use an oral syringe--rather than a cup-- to measure the dose, a recent trial showed.
FDA warns about dosing errors with antifungalAfter a death and a hospitalized patient, FDA is cautioning that differences in dosing regimens between the 2 oral formulations of Merck’s antifungal drug Noxafil (posaconazole) have resulted in dosing errors.
FDA warns of joint pain for DPP-4 diabetes drugs
FDA warns of joint pain for DPP-4 diabetes drugsFDA warned this week that several leading drugs for type 2 diabetes may cause severe and disabling joint pain. FDA said that sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain, and added a new Warning and Precaution about this risk to the labels of all dipeptidyl peptidase-4 (DPP-4) inhibitors.
FDA warns about problems with Proglycem in infantsFDA is warning that diazoxide (Proglycem) for low blood sugar has caused pulmonary hypertension (high pressure in the blood vessels leading to the lungs) in infants and newborns.
FDA, PatientsLikeMe partner on drug safety dataThe Food and Drug Administration (FDA) and PatientsLikeMe will work together to determine how patient-reported data can give new insights into drug safety.
Be vigilant of counterfeit version of Botox found in United StatesA counterfeit version of onabotulinumtoxinA (Botox) was found in the United States and may have been sold to doctors’ offices and medical clinics nationwide. The version is considered unsafe and should not be used.